Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReABLE-II trial of Yisaipu plus methotrexate in active rheumatoid arthritis
ChiCTR1900024107Phase 4Completed
- Sponsor
- Chinese Academy of Medical Sciences & Peking Union Medical College Hospital
- Start
- Oct 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of etanercept and methotrexate in rheumatoid arthritis (RA), sponsored by Chinese Academy of Medical Sciences & Peking Union Medical College Hospital. Started Oct 2010; status: completed.
02
Drugs
etanerceptmethotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR1900024107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024107.